Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus
- PMID: 2535741
- PMCID: PMC247697
- DOI: 10.1128/JVI.63.1.403-410.1989
Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus
Abstract
The processing pathway of the major envelope glycoprotein complex, gp55-116 (gB), of human cytomegalovirus was studied using inhibitors of glycosylation and endoglycosidases. The results of these studies indicated that the mature gp55-116 is synthesized by the addition of both simple and complex N-linked sugars to a nonglycosylated precursor of estimated Mr 105,000. In a rapid processing step, the Mr 105,000 precursor is glycosylated to a protein of Mr 150,000 (gp150) which contains only endoglycosidase H-sensitive sugar linkages. The gp150 is then processed relatively slowly to a Mr 165,000 to 170,000 species (gp165-170), which is then cleaved to yield the mature gp55-116. Monensin prevented the final processing steps of the gp150, including cleavage, suggesting that transport through the Golgi apparatus is required for complete processing. Digestion of the intracellular forms of this complex as well as the virion forms confirmed the above findings and indicated that the mature virion form of gp55 contains 8,000 daltons of N-linked sugars. The virion gp116 contains some 52,000 to 57,000 daltons of N-linked carbohydrates and approximately 5,000 daltons of O-linked sugars.
Similar articles
-
Characterization of a human cytomegalovirus glycoprotein complex (gcI).J Gen Virol. 1988 Jun;69 ( Pt 6):1205-15. doi: 10.1099/0022-1317-69-6-1205. J Gen Virol. 1988. PMID: 2838571
-
Synthesis and processing of the major envelope glycoprotein of murine cytomegalovirus.Virology. 1991 Jan;180(1):239-50. doi: 10.1016/0042-6822(91)90028-a. Virology. 1991. PMID: 1845824
-
Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus.J Virol. 1986 Apr;58(1):185-91. doi: 10.1128/JVI.58.1.185-191.1986. J Virol. 1986. PMID: 3005648 Free PMC article.
-
N-glycosylation/deglycosylation as a mechanism for the post-translational modification/remodification of proteins.Glycoconj J. 1995 Jun;12(3):183-93. doi: 10.1007/BF00731318. Glycoconj J. 1995. PMID: 7496130 Review. No abstract available.
-
Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases.Anal Biochem. 1989 Aug 1;180(2):195-204. doi: 10.1016/0003-2697(89)90115-2. Anal Biochem. 1989. PMID: 2510544 Review. No abstract available.
Cited by
-
Synthetic DNA approach to cytomegalovirus vaccine/immune therapy.Adv Exp Med Biol. 2015;848:131-48. doi: 10.1007/978-1-4939-2432-5_7. Adv Exp Med Biol. 2015. PMID: 25757619 Free PMC article. Review.
-
Characterization of cytomegalovirus glycoproteins in a family of complexes designated gC-II with murine monoclonal antibodies.Arch Virol. 1990;112(1-2):55-65. doi: 10.1007/BF01348985. Arch Virol. 1990. PMID: 2164376
-
Development of novel vaccines against human cytomegalovirus.Hum Vaccin Immunother. 2019;15(11):2673-2683. doi: 10.1080/21645515.2019.1593729. Epub 2019 Apr 24. Hum Vaccin Immunother. 2019. PMID: 31017831 Free PMC article. Review.
-
Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo.J Virol. 2009 Aug;83(15):7495-506. doi: 10.1128/JVI.00400-09. Epub 2009 May 27. J Virol. 2009. PMID: 19474103 Free PMC article.
-
A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus.J Virol. 1992 Sep;66(9):5290-7. doi: 10.1128/JVI.66.9.5290-5297.1992. J Virol. 1992. PMID: 1323695 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources